Mesa Laboratories Inc
NASDAQ:MLAB
Net Margin
Mesa Laboratories Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
525.7m USD |
-1%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
231.5B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
191.5B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.7B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
149.2B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.5B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.5B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.7B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.6B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
275.8B CNY |
31%
|
Mesa Laboratories Inc
Glance View
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Mesa Laboratories Inc's most recent financial statements, the company has Net Margin of -0.8%.
You don't have any saved screeners yet